The hyperactivation of the β-catenin signalling pathway has been linked to elevated expressions of CTLA-4 and IL-10 in human melanomas, thereby establishing an immunosuppressive tumour microenvironment that favours tumour-cell proliferation [38, 54]. The gene discussed is CTLA4; the disease is melanoma.